Company: VRCA
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001193125-25-087838
Chunk: 45

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 45
---
 of exercise, such holder, together with such holder’s affiliates and any other person whose beneficial ownership of |

33

| (4) | This information has been obtained from a Schedule 13G/A filed on February 14, 2025 by entities and individuals associated with Perceptive Advisors LLC (“Perceptive Advisors”). Consists of (a) 3,249,669 shares of common stock and (b) 1,481,481 shares of common stock issuable upon exercise of warrants within 60 days of April 1, 2025 held by Perceptive Life Sciences Master Fund, Ltd. (the “Perceptive Master Fund”). Perceptive Advisors serves as the investment manager to the Perceptive Master Fund and may be deemed to beneficially own the securities directly held by the Perceptive Master Fund. Joseph Edelman is the managing member of Perceptive Advisors and may be deemed to beneficially own the securities directly held by the Perceptive Master Fund. The address of Perceptive Advisors is 51 Astor Place, 10th Floor, New York, NY 10016. |

| (5) | Consists of (a) 1,873,800 shares of common stock and (b) 1,123,594 shares of common stock issuable upon the exercise of warrants within 60 days of April 1, 2025. |

| (6) | Consists of (a) 889,881 shares of common stock, (b) 267,500 shares of common stock issuable upon the exercise of options within 60 days of April 1, 2025 and (c) 280,898 shares of common stock issuable upon the exercise of warrants within 60 days of April 1, 2025. |

| (7) | Consists solely of common stock underlying options that are exercisable within 60 days of April 1, 2025. |

| (8) | Consists of (a) 146,458 shares of common stock and (b) 395,738 shares of common stock issuable upon the exercise of options within 60 days of April 1, 2025. |

| (9) | Consists of (a) 100 shares of common stock and (b) 64,712 shares of common stock issuable upon the exercise of options within 60 days of April 1, 2025. |

| (10) | Consists of shares of common stock. |

| (11) |